1 Clinically important upper GI bleeding |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
1.1 TPN vs ranitidine + TPN |
1 |
54 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.8 [0.05, 12.14] |
1.2 TPN vs sucralfate + TPN |
1 |
49 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.32 [0.03, 3.26] |
2 All‐cause mortality in ICU |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
2.1 TPN vs ranitidine + TPN |
1 |
54 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.12 [0.41, 3.09] |
2.2 TPN vs sucralfate + TPN |
1 |
49 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.63 [0.26, 1.52] |
3 Duration of intubation |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
Subtotals only |
3.1 TPN vs ranitidine + TPN |
1 |
54 |
Mean Difference (IV, Fixed, 95% CI) |
‐2.0 [‐9.53, 5.53] |
3.2 TPN vs sucralfate + TPN |
1 |
49 |
Mean Difference (IV, Fixed, 95% CI) |
3.0 [‐1.50, 7.50] |